Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > FDA approval?

<< Previous

Bullboard Posts

Next >>

Comment by Zamperon Dec 31, 2019 12:06pm

272 Views

Post# 30505537

RE:FDA approval?

As they mentioned in one of teh NR that NVCN will submit the application for FDA approval before the end of 2020 and they did.

As this time they already have a reasons and notes from FDA thats why they fail last time and even FDA give them a guidelines or, help NVCN to proceed further with FDA approval.

As per my nderstanding this time they will get it...GLTA

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"